Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Short-term Investments (2018 - 2025)

Historic Short-term Investments for Abeona Therapeutics (ABEO) over the last 10 years, with Q3 2025 value amounting to $124.2 million.

  • Abeona Therapeutics' Short-term Investments rose 3219.79% to $124.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $124.2 million, marking a year-over-year increase of 3219.79%. This contributed to the annual value of $74.4 million for FY2024, which is 9697.24% up from last year.
  • According to the latest figures from Q3 2025, Abeona Therapeutics' Short-term Investments is $124.2 million, which was up 3219.79% from $62.0 million recorded in Q2 2025.
  • Abeona Therapeutics' Short-term Investments' 5-year high stood at $124.2 million during Q3 2025, with a 5-year trough of $11.0 million in Q1 2022.
  • For the 5-year period, Abeona Therapeutics' Short-term Investments averaged around $49.6 million, with its median value being $44.8 million (2024).
  • As far as peak fluctuations go, Abeona Therapeutics' Short-term Investments crashed by 8533.93% in 2021, and later surged by 29441.85% in 2023.
  • Quarter analysis of 5 years shows Abeona Therapeutics' Short-term Investments stood at $12.1 million in 2021, then surged by 213.85% to $37.9 million in 2022, then dropped by 0.47% to $37.8 million in 2023, then skyrocketed by 96.97% to $74.4 million in 2024, then skyrocketed by 67.06% to $124.2 million in 2025.
  • Its Short-term Investments was $124.2 million in Q3 2025, compared to $62.0 million in Q2 2025 and $68.2 million in Q1 2025.